A global leader in animal health

Both Intervet and Schering-Plough Animal Health (SPAH) were built on a judicious combination of organic growth and strategic acquisitions. The success of that approach is reflected in recent performance, with each business growing faster than the animal health industry average.

The integration of Intervet and SPAH, following the purchase of Organon BioSciences by Schering-Plough in November 2007, has created a new, truly world- class animal health business. Combined Intervet/Schering-Plough Animal Health sales in 2007 were equivalent to a 15% share of the global market.

Be it by region, product segment or species – Intervet/Schering-Plough Animal Health is now a leading force** in animal health:

• number one animal health company in Western Europe, Latin America, the Far East and Eastern Europe – four key regions which account together for almost two-thirds of all animal health product sales

• the leading supplier of products for use in cattle, sheep, poultry, swine and fish – species in which 60% of all veterinary products are used

• the world's biggest manufacturer of veterinary biologicals, which represent almost a quarter of global market value

• holds leadership positions in fertility management and bovine respiratory disease treatment

• holds a leadership position in aquatic animal health.

The combination of the two businesses has strengthened our position in a number of other key areas, enabling us to offer customers an enhanced range of services and establishing a solid platform on which to build for future growth.

   ^{*Derived from adding FY 2007 sales Schering-Plough Animal Health and Intervet
** Vetnosis and company data}